Shady Grove Fertility – FDA 483, Mar 2, 2020
An FDA inspection of Shady Grove Fertility in Rockville, MD, a reproductive human tissue establishment, revealed critical deficiencies in donor screening processes. The firm failed to adequately screen donors for communicable disease risks, properly document reasons for donor ineligibility, and apply appropriate warning labels to human cells, tissues, and cellular and tissue-based products (HCT/Ps) from ineligible donors. These observations highlight significant concerns regarding donor eligibility determination and product safety.
ID · c09cb123-7c87-401b-9e6f-daad362935f7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.